• Swiss medical weekly · Sep 1987

    [Trends in and distribution of lung cancer in Switzerland].

    • G Schüler.
    • Kantonalzürcherisches Krebsregister und Biostatistisches Zentrum Medizinischen Fakultät, Zürich.
    • Swiss Med Wkly. 1987 Sep 26; 117 (39): 1491-4.

    AbstractRecent trends in lung cancer mortality in Switzerland and the distribution of this cancer by districts, linguistic regions, and occupations are described. In 1985 7.5% of male deaths were due to the disease; female lung cancer is increasing (male-female ratio of deaths 1985: 5.9;in the age-class 35-44: 1.5). From 1970 to 1980, lung cancer became more frequent in the French-speaking area than in the rest of Switzerland. The geographic distribution shows a correlation with population density (chiefly in the over 65 age group) and there were high rates in agglomerations such as Basle and in some peripheral regions. The impact of smoking and occupational/environmental factors on the distribution of lung cancer by regions and occupations is discussed.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.